Contraception
Volume 78, Issue 4, Supplement , Pages S36-S41 , October 2008

Public–private partnerships advance contraceptive research and development

Received 25 March 2008 ,Accepted 25 March 2008.

References 

  1. Pincus G, Chang MC. The effects of progesterone and related compounds on ovulation and early development in the rabbit. Acta Physiol Lat Am. 1953;3:177–183
  2. Garcia CR, Rock J, Pincus G. Effects of certain 19-norsteroids on the normal human menstrual cycle. Science. 1956;124:891–893
  3. Rock J, Garcia CR, Pincus G. Synthetic progestins in the normal human menstrual cycle. Rec Prog Horm Res. 1957;13:323–339
  4.  Thompson KDo men want new contraceptive options? Do women? Initial results from an ongoing survey. Male Contracept Q. 2006;14;See http://www.imccoalition.org/facts/Male_Contraception_Quarterly_1.pdf
  5. Heinemann K, Saad F, Wiesemes M, White S, Heinemann L. Attitudes to male fertility control: results of a multinational survey on four continents. Hum Reprod. 2005;20:549–556
  6.  Au SCL,  Hinton BT,  Wong PYDPost-meiotic approaches to male contraception. Focusing on potential targets. Mol Cell Endocrinol. 2006;250:1–213
  7. World Health Organization Task Force on Methods for the Regulation of Male Fertility . Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men. Fertil Steril. 1996;65:821–829
  8. Stafford N. Big Pharma not interested in “male pill”?. http://135.196.210.195/chemistryworld/News/2007/June/22060701.asp2007;[Accessed March 24, 2008]
  9. Cheng CY, Mruk D, Silvestrini B, et al. AF-2364 [1-(2,4-dichlorobenzyl)-1H-indazole-3-carbohydrazide] is a potential male contraceptive: a review of recent data. Contraception. 2005;72:251–261
  10. Mruk DD, Wong C-H, Silvestrini B, Cheng YC. A male contraceptive targeting germ cell adhesion. Nature Med. 2006;12:1323–1328
  11. Pharmaco-Economics Working Group of the Rockefeller Foundation Microbicide Initiative. In: The economics of microbicide development. A case for investment. 2001;p. 23;http://www.microbicide.org/microbicideinfo/rockefeller/pharmaeconomics.document.rockfound.pdf[Accessed March 24, 2008]
  12. Mauck CK, Freziers RG, Walsh TL, Peacock K, Schwartz JL, Callahan MM. Noncomparative contraceptive efficacy of cellulose sulfate gel. Obstet Gynecol. 2008;111:739–746
  13. Widdus R, White K. Combating diseases associated with poverty. Financing strategies for product development and the potential role of public–private partnerships. Geneva: The Initiative on Public–Private Partnerships for Health, Global Forum for Health Research. November 2004; p. 214 (ISBN 2-940286-21-3).
  14. Buse K, Hammer A. Global health: making partnerships work. Overseas Development Institute, UK Briefing Paper 2007; p. 4. http://www.odi.org.uk/Publications/briefing/bp_jan07_global_health.pdf [Accessed March 24, 2008] [This is a summary of original research published by the authors: Buse K, Harmer A. Seven habits of highly effective global public private health partnerships: practice and potential. Social Sci Med 2007;64:259–271.]
  15. Bata MS, Al-Ramahi M, Salhab AS, Gharaibeh MN, Schwartz J. Delay of ovulation by meloxicam in healthy cycling volunteers: a placebo-controlled, double-blind, crossover study. J Clin Pharmacol. 2006;46:925–932
  16. Massai MR, Forcedello ML, Brache V, et al. Does meloxicam increase the incidence of anovulation induced by a single administration of levonorgestrel in emergency contraception? A pilot study. Hum Reprod. 2007;22:434–439
  17. All Party Parliamentary Group on Population, Development and Reproductive Health. Return of the population growth factor: its impact on the Millennium Development Goals. http://www.appg-popdevrh.org.uk2007;[accessed March 24, 2008]
  18. Campbell M, Cleland J, Ezeh A, Prata N. Return of the population growth factor. Science. 2007;315:1501–1502
  19. Campbell OMR, Graham WJ. The Lancet Maternal Survival series steering group. Strategies for reducing maternal mortality: getting on with what works. Lancet. 2006;368:1284–1299
  20. Collumbien M, Gerressu M, Cleland J. Non-use and use of ineffective methods of contraception. In:  Ezzati M,  Lopez A,  Rodgers A,  Murray C editor. Quantification of health risks: global and regional burden of disease attributable to selected major risk factors. Geneva: World Health Organization; 2004;p. 1255–1319[Chap 15] http://www.who.int/publications/cra/chapters/volume2/1255–1320.pdf[Accessed May 8, 2007]
  21. Potts M, Fotso JC. Population growth and the Millennium Development Goals. Lancet. 2007;369:354–355
  22. Speidel JJ, Grossman RA. Family planning and access to safe and legal abortion are vital to safeguard the environment. Contraception. 2007;76:415–417

 Please see the Author Disclosures section at the end of this article.

PII: S0010-7824(08)00275-8

doi: 10.1016/j.contraception.2008.03.017

Contraception
Volume 78, Issue 4, Supplement , Pages S36-S41 , October 2008

Article Tools